Enanta Pharmaceuticals (ENTA) Other Non-Current Liabilities (2012 - 2026)
Enanta Pharmaceuticals (ENTA) recorded Other Non-Current Liabilities of $88.29 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 26.4% from $119.94 million a year earlier and down 9.3% from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals reported Other Non-Current Liabilities of $111.13 million, down 17.5% from FY2024.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of 152.7% (FY2020 to FY2025).
- Across earlier fiscal years, Other Non-Current Liabilities came in at $134.78 million in FY2024 (-15.5%), $159.43 million in FY2023, $454,000 in FY2022 (-18.6%) and $558,000 in FY2021 (-48.2%).
- The fiscal Q3 2026 figure is the lowest quarterly Other Non-Current Liabilities since fiscal Q2 2023.
- On a year-over-year basis, Other Non-Current Liabilities has declined for nine consecutive quarters, with an average decline of 18.4% over the last eight quarters.
- Across the past five years, year-over-year decline in Other Non-Current Liabilities ran from 11.9% in fiscal Q2 2022 to 53.4% in fiscal Q2 2023.
- Per Business Quant, the preceding three fiscal quarters came in at $97.31 million (Q2 2026), $102.82 million (Q1 2026) and $111.13 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Enanta Pharmaceuticals | 383.80 Mn | -344.19 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 88.29 Mn |
| Mar 31, 2026 | 97.31 Mn |
| Dec 31, 2025 | 102.82 Mn |
| Sep 30, 2025 | 111.13 Mn |
| Jun 30, 2025 | 119.94 Mn |
| Mar 31, 2025 | 125.38 Mn |
| Dec 31, 2024 | 129.74 Mn |
| Sep 30, 2024 | 134.78 Mn |
| Jun 30, 2024 | 141.89 Mn |
| Mar 31, 2024 | 147.78 Mn |
| Dec 31, 2023 | 151.61 Mn |
| Sep 30, 2023 | 159.43 Mn |
| Jun 30, 2023 | 164.98 Mn |
| Mar 31, 2023 | 408,000.00 |
| Dec 31, 2022 | 414,000.00 |
| Sep 30, 2022 | 454,000.00 |
| Jun 30, 2022 | 441,000.00 |
| Mar 31, 2022 | 876,000.00 |
| Dec 31, 2021 | 856,000.00 |
| Sep 30, 2021 | 558,000.00 |
API Access
Enanta Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();